Goals · Recovery & Repair
Chronic pain and systemic inflammation. Anti-inflammatory peptides, autoimmune modulators.
Compounds linked to this goal in the catalogue, ordered by role — primary, then support, then optional. Roles follow peptide-db's per-use effectiveness rating (most effective → primary, effective → support, moderate or thinner → optional); a compound that reaches the goal through a curated stack or a condition page says so. Click any card for the full mechanism, dosing, and evidence.
Body Protection Compound-157 | Pentadecapeptide
Half-life: <30 minutes
Anti-Inflammatory Tripeptide | Alpha-MSH Fragment
Half-life: 1-2 hours
Thymosin β4 · 43-amino-acid regenerative peptide
Half-life: ~2 hours
AEDL Tetrapeptide | Bronchial Bioregulator
Half-life: Minutes (short peptide); effects persist via epigenetic changes
Support — Bronchial Function · effective
EDG Tripeptide | Bronchial/Lung Bioregulator
Half-life: Minutes (short peptide); effects persist via epigenetic changes
Support — Bronchial Function · effective
Acetyl Octapeptide-3 | Anti-Wrinkle & Expression Line Peptide
Half-life: Not established (primarily topical use)
Support — SNARE Complex Modulation · effective
Synthetic Thymic Hormone | Immune System Modulator
Half-life: ~2 hours
Support — Cytokine Reduction · effective
Tissue-Protective Peptide | Innate Repair Receptor Agonist
Half-life: ~20 minutes (SubQ), ~2 minutes (IV)
Optional — Cytokine Reduction · moderate
Copper Peptide | Skin Regeneration & Anti-Aging Compound
Half-life: 0.5-2 hours
Optional — Immune Modulation · moderate
FTS | Zinc-Dependent Thymic Nonapeptide
Half-life: ~10 minutes (free form); extended with nanoparticle formulations
Optional — Anti-Inflammatory Effects · moderate
BPC-157 + TB-500 | Tissue Repair & Recovery Protocol
Optional — Inflammatory Cytokine Reduction · moderate
No SARMs tagged for this goal yet.
Beta-2 Agonist | Thermogenic Fat Loss
Half-life: ~36 hours
Opioid Antagonist | Low-Dose Anti-Inflammatory & Immune Modulation
Half-life: ~4 hours
Support — Inflammatory Bowel Disease (Crohn's & Ulcerative Colitis) · effective
PDE5 Inhibitor | Erectile Function & Pulmonary Hypertension
Half-life: ~3-5 hours
Support — Neonatal Persistent Pulmonary Hypertension · effective
Mucolytic | Glutathione Precursor | FDA-Approved Drug
Half-life: ~6 hours (oral); plasma cysteine elevation persists ~12 hours
Optional — COPD Exacerbation Reduction · moderate